MZT2A serves as a prognostic biomarker and promotes the progression of kidney renal clear cell carcinoma
Article in Heliyon (August 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Heliyon (August 2024)
Article in Immunological Investigations (May 2024)
Article in Analytical Cellular Pathology (February 2024)